Investor Presentaiton

Despite modest performance, PSAI continues to be strategic differentiator REVENUES (US $ mn) 500 590 . • STRATEGIC FOCUS Accelerate first-to-market access for our partners through non-infringing IP positions Invest in technology platforms to develop complex APIs Supply reliability to meet customer demands 417 400 345 FY12 FY13 FY14 FY15 FY16 Partnerships with top Generics players: ~40% of sales from global top 5 >60% of Global Generics segment's sales from vertically integrated APIs

View entire presentation